Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore.

Enhancing Survival Through Innovative Immune Modulation

We are a clinical-stage microbiome therapeutics company
aiming to improve survival in cancer.

Our strengths

A full ecosystem approach

Oncology focused

AI-Powered Drug Development

cGMP Versatile Manufacturing Capacities

Latest News

January 27, 2025

January 13, 2025: Microbiote : résultats positifs d’une étude clinique – Ouest France (French Only)

January 27, 2025

January 13, 2025: ARES Trial of MaaT013 in Acute GVHD Meets Primary End Point – Targeted Oncology

January 27, 2025

January 10, 2025: MaaT013 Elicits Durable Responses in Acute Graft-vs-Host Disease – Cancer Network

Like what you see? See more posts

Our upcoming events

Event
January 24, 2025

“Journée Microbiotes et Santé”

• January 23, 2025 –"Journée Microbiotes et Santé" organized by Lyonbiopôle
MaaT Pharma
Event
January 24, 2025

17th « Journée GREFFE» of the IPC

• January 25, 2025 – 17th « Journée GREFFE» of the Paoli-Calmettes Institute
MaaT Pharma
Event
January 24, 2025

9th Annual Microbiome Movement Summit

• January 28-30, 2025 – 9th Annual Microbiome Movement Summit
MaaT Pharma

Join the MaaT Pharma adventure!

Bring your talents, your passion and join an inclusive, creative, and multidisciplinary team. We aim to leverage the potential of microbiome to improve the treatment of patients with cancer.

Learn more about our values, our environment and see what we have to offer to you!

Careers